Bridging fulminant myocarditis patients to recovery or advanced therapies with veno-arterial extracorporeal membrane oxygenation:a single-center retrospective study  

作　　者：Jing Wang Gang Liu Yuan Teng Jian Wang Shujie Yan Qian Wang Tianlong Wang Han Zhang Bingyang Ji 

机构地区：[1]Department of Cardiopulmonary Bypass,Fuwai Hospital,National Center for Cardiovascular Disease,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100037,China

出　　处：《World Journal of Emergency Medicine》2024年第6期481-485,共5页世界急诊医学杂志（英文）

基　　金：funded by CAMS Innovation Fund for Medical Sciences(CIFMS)(NO.2020-I2M-C&T-B-054).

摘　　要：Fulminant myocarditis(FM)is a severe inflammatory cardiac disease,typically triggered by viral pathogens or autoimmune disorders.[1,2]Early symptoms of the disease can be mild and nonspecific,but in certain cases,patients may experience sudden and severe heart failure,arrhythmias,refractory cardiogenic shock,or even death.

关 键 词：PATIENTS MYOCARDITIS CARDIAC 

分 类 号：R542.21[医药卫生—心血管疾病]